Other Issues:
previous
| next | latest |
archive
Volume 5(2); June 2007
Articles
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
John C Ashton and Michelle Glass
Curr Neuropharmacol.
2007 June;
5
(2)
: 73–80.
PMCID:
PMC2435344
|
Abstract
|
Full Text
|
PDF–175K
|
Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Balapal S Basavarajappa
Curr Neuropharmacol.
2007 June;
5
(2)
: 81–97.
PMCID:
PMC2139910
|
Abstract
|
Full Text
|
PDF–572K
|
Parkinson’s Disease: Genetics and Beyond
NN Inamdar, DK Arulmozhi, A Tandon, and SL Bodhankar
Curr Neuropharmacol.
2007 June;
5
(2)
: 99–113.
PMCID:
PMC2435348
|
Abstract
|
Full Text
|
PDF–314K
|
Cell and Gene Therapies for Refractory Epilepsy
Boison Detlev
Curr Neuropharmacol.
2007 June;
5
(2)
: 115–125.
PMCID:
PMC2435346
|
Abstract
|
Full Text
|
PDF–244K
|
Current Experimental Therapy for Alzheimer’s Disease
Sheng Chen, Xiao-Jie Zhang, Liang Li, and Wei-Dong Le
Curr Neuropharmacol.
2007 June;
5
(2)
: 127–134.
PMCID:
PMC2435347
|
Abstract
|
Full Text
|
PDF–336K
|
The Neurobiological Bases for Development of Pharmacological Treatments of Aggressive Disorders
Allan Siegel, Suresh Bhatt, Rekha Bhatt, and Steven S Zalcman
Curr Neuropharmacol.
2007 June;
5
(2)
: 135–147.
PMCID:
PMC2435345
|
Abstract
|
Full Text
|
PDF–428K
|
Other Issues:
previous
| next | latest |
archive
